LANCE L. GOOBERMAN, M.D., J.D., D.A.B.A.M.

One South Centre Street
Merchantville, New Jersey 08109
(856) 663-8811
(856) 912-3977 Cell
(856) 488-6380 Fax

Email: [email protected]
Website: www.lancegooberman.com

Personal

Date of Birth : August 1, 1951
Married : Three children
Bilingual : English & Spanish

Education

  • Pennsauken High School Pennsauken, New Jersey 1966-1970
  • Findlay College Findlay, Ohio 1970-1971
  • Rutgers University Camden, New Jersey 1971
  • Camden County College Blackwood, New Jersey 1972-1973
  • Autonomous University of Guadalajara Guadalajara, Mexico 1973-1974
  • Autonomous University of Ciudad Juarez Ciudad Juarez, Mexico 1974-1978
  • University of Texas at El Paso El Paso, Texas 1977
  • Widener University School of Law Wilmington, Delaware 2001 – 2004

Internship & Residentency Training

  • Wilmington Medical Center Wilmington, Delaware Rotating Internship 1979-1980
  • Cooper Hospital/University Medical Center March 1980-April 1982
  • Camden, New Jersey Residency, Internal Medicine April 1983-July 1983

Licensure

-MEDICAL 
    • New Jersey 25MA03819100-Issued 1980
    • Pennsylvania MD-038545-L-Issued 1980
    • CDS-NJ D03066600
    • DEA BG9594412
    • DEA Suboxone Waiver XG9594412
    • Physician Approval to the New Jersey Medical Marijuana Program – March 2014
-LAW
    • Admitted to the Bar of the Commonwealth of Pennsylvania 2005 – ID 201260
    • Admitted to the Bar of State of New Jersey – May 15, 2007 – ID 019032005

Employment History

  • Emergency Physician Associates Emergency Room West Jersey Health Systems Voorhees, New Jersey April 1982 to April 1983
  • Cooper Hospital Pain Center Cooper Hospital, University Medical Center Camden, NJ Medical Consultant May 1982 to April 1983
  • Private Practice: Internal Medicine 1982 to 1996
  • Addiction Medicine 1987 to June 2003 2005 to Present
  • Forensic Addiction Medicine 1993 to June 2003 2005 to Present Merchantville, New Jersey
  • President Breath Alcohol Testing, Inc. Merchantville, New Jersey 1993 to 1995
  • Founder, President, Chief Medical Officer 1995 to May 2003 U.S. Detox, Inc. Merchantville, New Jersey 1995 to June 2003
  • NaltrexZone L.L.C. May 2003 to present Pellet Technologies L.L.C. January 1, 2009 – Present
  • Interlock Device of New Jersey L. L. C. January 1, 2009 – Present
  • Addiction and Detoxification Institute LLC June 1, 2005 – Present
* My medical licenses were suspended for five years, two years active and three years stayed, May 1, 2003 to May 1, 2008, as part of a settlement agreement with the New Jersey Board of Medical Examiners after a case that presented a number of difficult issues that required consideration of the proper role and limits of innovation and the weighing of the risks and benefits of a potentially beneficial procedure, rapid opiate detoxification (ROD). There were no findings of fact or conclusions of law.

HOSPITAL APPOINTMENTS & PRIVILEGES (1982-2003)

  • Cooper Hospital, University Medical Center | Our Lady of Lourdes Medical Center
  • Camden, New Jersey | Camden, New Jersey Staff Physician | Staff Physician
  • West Jersey Health Systems | Underwood
  • Memorial Hospital Camden, Voorhees, Berlin & Marlton Division | Woodbury, New Jersey
  • Staff Physician | Staff Physician
  • Admitting Privileges-Detoxification Unit Kennedy Health System Cherry Hill, New Jersey Staff Physician

FELLOWSHIPS

  • The American Society of Addiction Medicine 1999
  • American College of Legal Medicine (ACLM) Fellowship 2006

CERTIFICATIONS

  • Educational Commission for Foreign Medical Graduates | 1979
  • American Society of Addiction Medicine | 1990
  • National Draeger, Inc. Breathalyzer Operator Course 900/900A | 1993
  • National Draeger, Inc. Breathalyzer Level I Trainer Instructor | 1994
  • National Draeger, Inc. Breathalyzer 7410 Training | 1998
  • Draeger Safety Diagnostics Inc. Operator Training Course for the Draeger Alcotest 7110 MKIII-C Version NJ 3.11’s,analytical system, components and peripherals as well a show to operate the instrument and perform a New Jersey specific breath test sequence. | 2008-2012
  • Diplomat of the American Board of Addiction Medicine | 2009
  • Axion Training Institute, Inc. Analytical Laboratories, Inc. Forensic Chromatography VIII: “Theory & Practice” | 2012
  • Axion Training Institute, Inc. Analytical Laboratories, Inc. Forensic Drug Analysis II | 2013

MEMBERSHIPS AND SOCIETIES

  • American Society of Addiction Medicine
  • American College of Legal Medicine
  • National College for DUI Defense
  • American Bar Association
  • New Jersey State Bar Association

CONTINUING EDUCATION

  • Upon Request

Teaching

  • “Effects of Alcohol on the Human Body” for the course Alcohol, Vehicles and the Law, Widener University School of Law, Wilmington, Delaware, Spring Semesters, 2000 – 2013.
  • “DWI-Alcohol and the Human Body” for the course Forensic Evidence, Widener University
    School of Law, Wilmington, Delaware, Spring Semester, 2012, 2013

PRESENTATIONS

International
  • Lecturer: “Development in Rapid Opiate Detoxification Under General Anesthesia: Experience with over 1,000 Patients in Four Countries;” 41st International Council on Alcohol & Addiction; International Institute, Cairo, Egypt, May 19, 1997
  • Lecturer: “Octreotide Prevents Diarrhea during Rapid Opiate Detoxification,” 41st International Council on Alcohol & Addictions; International Institute, Cairo, Egypt, May 19, 1997.
  • Lecturer: “Depo-Naltrexone Implants for Opiate Dependence: Clinical Experience, Plasma Levels, and Opiate Challenge, Results in over 200 Patients,” 41st International Council on Alcohol & Addictions; International Institute, Cairo, Egypt, May 19, 1997
  • Lecturer: “Naltrexone Implants” presented at the 4th International Stapleford Conference on Addiction Medicine at the Royal Society of Medicine, London, England, January 9, 1998.
  • Lecturer: “Drug Addiction-A Treatable Disease. New Treatments for Heroin Addiction” presented at the 1998 American Psychiatric Association Annual Conference, Toronto, Ontario, Canada, June 4, 1998.
  • Lecturer: “Opiate Reversal under General Anesthesia with Induction of Naltrexone Maintenance Therapy Utilizing Depo-Naltrexone Preparation” presented at the 10th European Congress of Anesthesiology, Frankford, Germany, July 3, 1998.
  • Lecturer: “The Outpatient ICU: An Ideal Setting for Rapid Opiate Detoxification” presented at the 23rd Australian and New Zealand Annual Scientific Meeting on Intensive Care, Adelaide, Australia, October 9, 1998.
  • Lecturer: “Naltrexone Pellets for Implantation” presented to Vilnius University, Vilnius, Lithuania, August 17, 2001.
  • Lecturer: “Naltrexone Pellets for Implantation” presented to Physicians and Pharmacists at the Detoxification Centre in Lisbon, Portugal, January 8, 2002.
  • Lecturer: “Development of Naltrexone Pellets” presented at the Wuhan International Naltrexone Depot Symposium 2007, Wuhan, China.
  • Lecturer: “Neuvas Opciones de Tratamiento” presented at Congreso Nacional De Pisquiatria Guatemala City, Guatemala, August 18-20, 2010
  • Contributor: “Other Approaches to the Treatment of Opiate Use Disorder”, International Society of Addiction Medicine, New Delhi, India, November, 2019.
National
  • Round table discussion with Governor-elect James Florio “The Perils of Drug and Alcohol Addiction,” Trenton, New Jersey, January 15, 1990
  • Panel on “Safe Homes” Program: Representing the Field of Addiction Medicine Bishop Eustace Preparatory School, Pennsauken, New Jersey, October 21, 1991
  • Chief Residents Conference “Managed Care Protocol for Addictions” Cooper Hospital, University Medical Center Camden, New Jersey, November 20, 1991
  • The Robyn Stevens Show, “Interview on Alcoholism,” Channel 13 TV, Turnersville, New Jersey, January 26, 1993
  • Chief Rounds; Panel Discussion Participant: “Alcoholism and Alcoholic Cardiomyopathy” Cooper Hospital, University Medical Center, Camden, New Jersey, February 4, 1993
  • 1993-1994 Internship Survival Lectures, “Alcohol/Narcotic Withdrawal,” Cooper Hospital, University Medical Center, Camden, New Jersey, August 13, 1993
  • Critical Care Education Day for Nurses, “The Addicted Critically Ill Patient,” West Jersey Health Systems, Camden, New Jersey, September 22, 1993
  • Lecture, “Rapid Opiate Detoxification,” sponsored by Ohmeda Pharmaceutical, New York City New York, January 23, 1996
  • Paper Session, “Rapid Opiate Detoxification,” American Society of Addiction Medicine, Atlanta, Georgia, April 19, 1996
  • Component Session, “Rapid Opiate Detoxification,” American Society of Addiction Medicine, Atlanta, Georgia, April 20, 1996
  • Course Director, “Evaluating Outcome of Opiate Detoxification under General Anesthesia: The Last 100 Years of Opiate Detoxification;” American Society of Addiction Medicine, 28th Annual Medical-Scientific Conference, San Diego, California, April 20, 1997
  • Lecturer: “Depo-Naltrexone after Opiate Reversal under General Anesthesia,” presented at the University of Pennsylvania, Department of Psychiatry, Treatment Research Center Seminar Series, Philadelphia, Pennsylvania, July 28, 1997.
  • Lecturer: “Heroin Addiction Treatment” presented at American Osteopathic Academy of Addiction Medicine, 102nd Annual AOA Conference and Scientific Seminar, San Antonio, Texas, October 20, 1997.
  • Lecturer: “DWI and Addiction Medicine Issues” presented at the American Society of Addiction Medicine, Medical Review Officer Forensic Issues in Addiction Medicine Conference, Atlanta, Georgia, February 19, 1998.
  • Poster Presentation: “Depo-Naltrexone versus Oral Naltrexone Post-Detoxification” presented at the American Society of Addiction Medicine, 29th Annual Medical Scientific Conference, New Orleans, Louisiana, April 17 – 19, 1998.
  • Lecturer: “Addiction Medicine: A Tool for Early Intervention, Component Session of Forensic Addiction Medicine” presented at the American Society of Addiction Medicine, 29th Annual Medical Scientific Conference, New Orleans, Louisiana, April 17 – 19, 1998.
  • Lecturer: “Antagonist Assisted Abstinence” presented to the Department of Medicine, West Jersey Health Systems, Voorhees, New Jersey, May 12, 1998.
  • Lecturer: “Rapid Opiate Detoxification” presented to Camden County Probation Department, Blackwood, New Jersey, November 5, 1998.
  • Poster Presentation: “Depo-Naltrexone for Protection against Opiate Defect in the Post Detoxification.” Presented at the 9th Annual Meeting and Symposium of the American Academy of Addiction Psychiatry, Amelia, Island, Florida, December 3 – 6, 1998.
  • Lecturer: “Antagonist Assisted Abstinence” presented to the Poison Control Center, Philadelphia, Pennsylvania, February 29, 2000.
  • Lecturer: “Rapid Detoxification Techniques” presented to the 11th Annual Clinical Meeting of the American Academy of Pain Management. Las Vegas, Nevada, September 23, 2000.
  • Lecturer: “An Alternative to Incarceration for Heroin Addicts” presented to Hunterdon County Probation Department, Flemington, New Jersey, October 2, 2001.
  • Lecturer “Preventing Precipitous Opiate Withdrawal and Antagonist Assisted Abstinence (A3)” Presented to Kennedy Health System, Department of Emergency Medicine, Stratford, New Jersey, November, 2006.
  • Lecturer: “Preventing Precipitous Opiate Withdrawal and Antagonist Assisted Abstinence (A3)” Presented to Kennedy Health System, Department of Psychiatry, Stratford, New Jersey, January 24, 2007.
  • Lecturer: “Addiction Law & DWI” presented at American College of Legal Medicine Conference, Orlando, Florida, March 5, 2010.
  • Lecturer: “Interlock Device” Presented to New Jersey State Bar Association, New Brunswick, New Jersey, March 15, 2010.
  • Lecturer: “Naltrexone” presented to Drexel University, Division of Toxicology, Department of Emergency Medicine, Philadelphia, Pa., May 4, 2010.
  • Lecturer: “Paradigm Shift in the Approach to Treatment of Addiction” presented at Grand Rounds – Texas Tech University School of Medicine, October 26, 2010.
  • Participant, Expert Panel: “Advance DWI Defense”, NJICLE, Newark, New Jersey, September 29, 2012.
  • Key Note Speaker: “ Medicine (DSM) vs. NHTSA in DWI Cases – A Comparison of How Real Science Gets Ignored” presented at the 20th Annual Mastering Scientific Evidence in DUI/DWI Cases. New Orleans, Louisiana, March 21, 2013
  • Lecturer: “Discovery: Field Sobriety Testing and Physiologically Based Defenses: and :Expert Witnesses: Blood/Breath/Physiology” presented to New Jersey State Bar Association, New Brunswick, New Jersey, July 10, 2014
  • Lecturer: “Cutting Edge Addiction Medicine and Detoxification” presented at the 57th Annual Meeting of American College of Legal Medicine, Las Vegas, Nevada, February 24, 2017.
  • Lecturer: “Medical Entrepreneurship” presented to Drexel University Medical School students, Philadelphia, PA, December 7, 2017.
  • Lecturer: “Medical Entrepreneurship” presented to Drexel University Medical School students, Philadelphia, PA, December 6, 2018.
  • Lecturer: “Addiction Medicine”, guest speaker on Inside Medicine, 610 ESPN Radio talk show, Philadelphia, PA, November 23, 2019.

PUBLICATIONS

  • Rapid Opiate Detoxification, Journal of Addictive Diseases, Volume 15, No. 2 (1996), Abstract 7, p. 117, Lance Gooberman, M.D., Thaddeus Bartter, M.D.
  • Rapid Opiate Detoxification, American Journal of Drug and Alcohol Abuse, Volume 22, No. 4, pp. 489-495(1996), Lance Gooberman, M.D., Thaddeus Bartter, M.D.
  • Rapid Opiate Detoxification and Naltrexone Induction under General Anesthesia and Assisted Ventilation: Experience with 510 Patients in Four Countries, In Press 1996, Acta Psychiatrica Belgica, Colin Brewer,M.R.C., Psych,Mary Laban, M.R.C.A., Charles Schmulian, F.F.A., Lance Gooberman, M.D., Yiannis Kasvikis,M.R.C.,Psych, Nabil Abdel Maksoud, M.D.
  • Rapid Opioid Detoxification, Journal of the American Medical Association, Letter to the Editor, Volume 279, No. 23, Page 1871, June 17, 1998, Lance L. Gooberman, M.D.
  • Using the Diagnostic and Statistical Manual to Raise the NHTSA-Created Low Threshold for Diagnosing Alcohol Intoxication, Understanding DUI Sc ientific Evidencde, 2013 Edition, pp.2710298, Lance Gooberman, M.D., D.A.B.A.M. and Ashley E. Killeen, JD.

AWARDS

Benjamin Franklin Emerging Business Award U.S. Detox Center, Merchantville, New Jersey Most Innovative Service, Philadelphia, Pennsylvania, November 1996

UNITED STATES PATENTS ISSUED

  • Improvement to Rapid Opioid Detoxification Patent Number 5,789,411 Issued August 4, 1998
  • Rapid Opiate Detoxification Patent Number 6,004,962 Issued December 21, 1999
  • Pharmaceutical Delivery Device and Method of Preparation Therefor Patent Number 6,203,813 Issued March 20, 2001
  • Pharmaceutical Delivery Systems for Treatment of Substance Abuse and Other Addictions Patent Number 8,791,093 Issued July 29, 2014
  • Anti-inflammatory Pharmaceutical Compositions and Methods of Administration Patent Number 10,568,842 Issued February 25, 2020
  • Anti-inflammatory Pharmaceutical Compositions and Methods of Administration Patent Number 11,033,510 Issued June 15, 2021

UNITED STATES PATENTS PENDING

  • Degradable Networks for Sustained Release and Controlled Release Depot Drug Delivery Applications Polymer Coated Implants – Blocking Plus Aversive Agents
  • Implants Containing Disulfiram and an Anti-Inflammatory Agent
    Disulfiram Pellets
  • Medicated Spray for Treatment of Addiction and Impulse Control Disorders
    Naltrexone Spray
  • Restrictive Cell Phone Use and Anti-Texting Apparatus and Methods
    Anti-Texting Ignition Interlock Device (ATIID)
    Opiate Antagonist Implant and Process for Preparation Therefor
  • Rapid Opiate Detoxification
  • Rapid Testing Apparatus and Method for Drugs and Compliance
  • Improved Degradable Networks for Sustained Release and Controlled Release Depot Drug Delivery
    Applications
  • Degradable Networks for Sustained Release and Controlled Release of Detectable Implanted Depot
    Drug Delivery Applications
  • Method for Treating Addiction with Implants Containing Disulfiram

Revised August, 2021